Efficiency of anti-B-cell therapy in patients with neuropsychiatric manifestations of systemic lupus erythematosus: a report of clinical cases

Efficiency of anti-B-cell therapy in patients with neuropsychiatric manifestations of systemic lupus erythematosus: a report of clinical cases

The paper describes two patients with systemic lupus erythematosus (SLE) with severe nervous system damage characterized by diffuse and focal neuropsychiatric manifestations of SLE due to of the central nervous system involvement and damage to the peripheral nervous system as local mononeuritis of t...

ver descrição completa

Detalhes bibliográficos
Principais autores:	G. M. Koilubaeva, E. A. Aseeva, S. K. Solovyev, N. Yu. Nikishina, E. L. Nasonov, А. S. Dzhumagulova, N. P. Tkachenko, Е. R. Karimova, A. A. Moldobaeva, A. Zh. Zhumakadyrova
Formato:	Artigo
Idioma:	Russian
Publicado em:	IMA PRESS LLC 2020-02-01
coleção:	Научно-практическая ревматология
Assuntos:	systemic lupus erythematosus neuropsychiatric manifestations central nervous system peripheral nervous system anti-b-cell therapy rituximab
Acesso em linha:	https://rsp.mediar-press.net/rsp/article/view/2851

Registros relacionados

Clinical and laboratory manifestations of systemic lupus erythematosus in patients with neuropsychiatric disorders (eurasian renaissance register)
por: G. M. Koilubaeva, et al.
Publicado em: (2019-11-01)

Neuropsychic manifestations in the Kyrgyz cohort of patients with systemic lupus erythematosus
por: G. M. Koylubaeva, et al.
Publicado em: (2019-03-01)

Juvenile systemic lupus erythematosus with primary neuropsychiatric presentation
por: Rajesh Kulkarni, et al.
Publicado em: (2023-01-01)

Therapeutic strategies in severe neuropsychiatric systemic lupus erythematosus: experience from a tertiary referral centre
por: F. De Leonardis, et al.
Publicado em: (2012-12-01)

Magnetic resonance imaging features of neuropsychiatric lupus
por: Mohan Suyash, et al.
Publicado em: (2006-01-01)

Sequential therapy with rituximab and belimumab in patients with systemic lupus erythematosus
por: A. A. Mesnyankina, et al.
Publicado em: (2020-11-01)

Anti-B cell therapy in patients with systemic lupus erythematosus
por: M. E. Tsanyan, et al.
Publicado em: (2018-01-01)

Research Progress in Antibodies Related to Autoimmune Encephalitis in Neuropsychiatric Systemic Lupus Erythematosus
por: CHEN Sixian, et al.
Publicado em: (2022-04-01)

THE EFFICIENCY OF BIOLOGICAL THERAPY AND THE FEATURES OF HUMORAL IMMUNITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
por: A. A. Mesnyankina, et al.
Publicado em: (2018-07-01)

Characteristics of systemic lupus erythematosus in patients of Asian ethnicity
por: G. M. Koilubaeva, et al.
Publicado em: (2025-02-01)

Rhupus – a combination of systemic lupus erythematosus and rheumatoid arthritis as a separate disease phenotype (a clinical case)
por: N. Yu. Nikishina, et al.
Publicado em: (2023-04-01)

Biomarkers in Neuropsychiatric Systemic Lupus Erythematosus: A Systematic Literature Review of the Last Decade
por: Julius Lindblom, et al.
Publicado em: (2022-01-01)

PROSPECTS FOR PHARMACOTHERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS
por: E. L. Nasonov, et al.
Publicado em: (2014-06-01)

Effect of biological agents on B-lymphocyte subpopulations in patients with systemic lupus erythematosus
por: A. A. Mesnyankina, et al.
Publicado em: (2019-03-01)

It’s never lupus: A case of atypical psychosis and neuropsychiatric lupus
por: S. Jesus, et al.
Publicado em: (2021-04-01)

Evaluation of Neurological Manifestations of Systemic Lupus Erythematosus
por: Ahmed Abdalrazak Rasheed Al Dulaimy, et al.
Publicado em: (2024-01-01)

Insights into the role of neutrophils in neuropsychiatric systemic lupus erythematosus: Current understanding and future directions
por: Tao Ming Sim, et al.
Publicado em: (2022-08-01)

Comprehensive Insights into Neuropsychiatric Systemic Lupus Erythematosus
por: Monika Turek, et al.
Publicado em: (2024-08-01)

Nitrated nucleosome levels and neuropsychiatric events in systemic lupus erythematosus; a multi-center retrospective case-control study
por: Isabel Ferreira, et al.
Publicado em: (2017-12-01)

Belimumab in the treatment of systemic lupus erythematosus: 20 years of basic research, 10 years of clinical practice
por: E. L. Nasonov, et al.
Publicado em: (2021-09-01)

Análise de prevalência e evolução das manifestações neuropsiquiátricas moderadas e graves em pacientes com lúpus eritematoso sistêmico internados no serviço de reumatologia do Hospital Geral de Fortaleza Prevalence and follow-up analysis of evolution of severe and moderate neuropsychiatric manifestations in hospitalized systemic lupus erythematosus in the rheumatology service of the Hospital General de Fortaleza
por: Walber Pinto Vieira, et al.
Publicado em: (2008-06-01)

The problem of fatigue in patients with systemic lupus erythematosus according to the data on a Russian RENAISSANCE cohort
por: E. A. Aseeva, et al.
Publicado em: (2020-11-01)

Correlation between neurofilament, HMGB1, MMP9, ds DNA blood levels and cognitive impairment in patients with neuropsychiatric systemic lupus erythematosus
por: Arman Ahmadzade, et al.
Publicado em: (2024-01-01)

Neurological complications in systemic lupus erythematosus and rheumatoid arthritis
por: Agnieszka Damiza-Detmer, et al.
Publicado em: (2018-12-01)

THE TIME COURSE OF CHANGES IN B LYMPHOCYTE SUBPOPULATIONS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS DURING THERAPY WITH BIOLOGICAL AGENTS
por: A. A. Mesnyankina, et al.
Publicado em: (2017-07-01)

Neuropsychiatric manifestations and magnetic resonance spectroscopy of the brain in systemic lupus erythematosus patients
por: Dina A. Shahin, et al.
Publicado em: (2023-04-01)

Neuropsychiatric lupus in Malaysian children: clinical characteristics, imaging features and 12-month outcomes
por: Sern Chin Lim, et al.
Publicado em: (2021-10-01)

Long-term results of therapy with sequential use of rituximab and belimumab in patients with systemic lupus erythematosus
por: S. K. Solovyev, et al.
Publicado em: (2023-10-01)

Upregulation of microRNA‐762 suppresses the expression of GIPC3 in systemic lupus erythematosus and neuropsychiatric systemic lupus erythematosus
por: Jijuan Yang, et al.
Publicado em: (2022-11-01)

Serum level of matrix metalloproteinase 3 (stromelysin 1) in patients with systemic lupus erythematosus: relation to clinical nephritis and neuropsychiatric manifestations
por: Taghreed F M. Mostafa, et al.
Publicado em: (2019-01-01)

Prevalence and risk factors of depression in juvenile systemic lupus erythematosus
por: Ika Dian Puspitanza, et al.
Publicado em: (2024-08-01)

Paradoxical Reaction during Treatment of Tuberculous Meningoencephalitis in a Patient with Systemic Lupus Erythematosus
por: Isadora Lemos Versiani, et al.
Publicado em: (2024-06-01)

Multi-voxel proton magnetic resonance spectroscopy changes in neuropsychiatric lupus patients
por: Page l. Wang, et al.
Publicado em: (2016-06-01)

Cognitive Performance in Patients with Systemic Lupus Erythematosus Using the Ped-ANAM
por: Jaqueline Cristina de Amorim, et al.
Publicado em: (2022-12-01)

Brain-reactive autoantibodies in neuropsychiatric systemic lupus erythematosus
por: Cristina Cocco, et al.
Publicado em: (2023-06-01)

DUAL THERAPY WITH BIOLOGICALS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
por: A. A. Mesnyankina, et al.
Publicado em: (2016-07-01)

Use of rituximab in systemic lupus erythematosus in children: a review
por: A. N. Arefyeva
Publicado em: (2019-11-01)

Neuropsychiatric Systemic Lupus Erythematosus: Molecules Involved in Its Imunopathogenesis, Clinical Features, and Treatment
por: Angel A. Justiz-Vaillant, et al.
Publicado em: (2024-02-01)

Experience in Rituximab Administration in Children with Systemic Lupus Erythematosus: a Retrospective Study of the Case Series
por: Mikhail M. Kostik, et al.
Publicado em: (2016-08-01)

Lipocalin-2 drives neuropsychiatric and cutaneous disease in MRL/lpr mice
por: Sayra J. Garcia, et al.
Publicado em: (2024-09-01)